3D bioprinting of tissues and organs

SV Murphy, A Atala - Nature biotechnology, 2014 - nature.com
Additive manufacturing, otherwise known as three-dimensional (3D) printing, is driving
major innovations in many areas, such as engineering, manufacturing, art, education and …

Engineering islets from stem cells for advanced therapies of diabetes

J Siehler, AK Blöchinger, M Meier… - Nature reviews Drug …, 2021 - nature.com
Diabetes mellitus is a metabolic disorder that affects more than 460 million people
worldwide. Type 1 diabetes (T1D) is caused by autoimmune destruction of β-cells, whereas …

[HTML][HTML] High-throughput screening enhances kidney organoid differentiation from human pluripotent stem cells and enables automated multidimensional …

SM Czerniecki, NM Cruz, JL Harder, R Menon, J Annis… - Cell stem cell, 2018 - cell.com
Organoids derived from human pluripotent stem cells are a potentially powerful tool for high-
throughput screening (HTS), but the complexity of organoid cultures poses a significant …

Reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cells

A Rezania, JE Bruin, P Arora, A Rubin… - Nature …, 2014 - nature.com
Transplantation of pancreatic progenitors or insulin-secreting cells derived from human
embryonic stem cells (hESCs) has been proposed as a therapy for diabetes. We describe a …

Controlled induction of human pancreatic progenitors produces functional beta‐like cells in vitro

HA Russ, AV Parent, JJ Ringler, TG Hennings… - The EMBO …, 2015 - embopress.org
Directed differentiation of human pluripotent stem cells into functional insulin‐producing
beta‐like cells holds great promise for cell replacement therapy for patients suffering from …

3D bioprinting in tissue engineering for medical applications: the classic and the hybrid

Z Xie, M Gao, AO Lobo, TJ Webster - Polymers, 2020 - mdpi.com
Three-dimensional (3D) printing, as one of the most popular recent additive manufacturing
processes, has shown strong potential for the fabrication of biostructures in the field of tissue …

Maturation of human embryonic stem cell–derived pancreatic progenitors into functional islets capable of treating pre-existing diabetes in mice

A Rezania, JE Bruin, MJ Riedel, M Mojibian, A Asadi… - Diabetes, 2012 - Am Diabetes Assoc
Diabetes is a chronic debilitating disease that results from insufficient production of insulin
from pancreatic β-cells. Islet cell replacement can effectively treat diabetes but is currently …

Pluripotent stem cells in regenerative medicine: challenges and recent progress

V Tabar, L Studer - Nature Reviews Genetics, 2014 - nature.com
After years of incremental progress, several recent studies have succeeded in deriving
disease-relevant cell types from human pluripotent stem cell (hPSC) sources. The prospect …

Efficient generation of NKX6-1+ pancreatic progenitors from multiple human pluripotent stem cell lines

MC Nostro, F Sarangi, C Yang, A Holland, AG Elefanty… - Stem cell reports, 2015 - cell.com
Human pluripotent stem cells (hPSCs) represent a renewable source of pancreatic beta
cells for both basic research and therapeutic applications. Given this outstanding potential …

Next-generation regenerative medicine: organogenesis from stem cells in 3D culture

Y Sasai - Cell stem cell, 2013 - cell.com
The behavior of stem cells, when they work collectively, can be much more sophisticated
than one might expect from their individual programming. This Perspective covers recent …